Table 2 Differences in individual factors between those who were aware of the Nagahama study and those who knew nothing about the Nagahama study from Qui-square test
Male (n=704) | Female (n=769) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Aware of the Nagahama study (n=210) % | Know nothing (n=483) % | OR | 95 % CI | P-value | Aware of the Nagahama study (n=381) % | Know nothing (n=376) % | OR | 95 % CI | P-value | |
Age group years) | ||||||||||
30–39 | 25.2 | 74.8 | 1 | 40.3 | 59.7 | 1 | ||||
40–49 | 20.9 | 79.1 | 0.78 | 0.43–1.41 | 0.415 | 43.7 | 56.3 | 1.15 | 0.74–1.78 | 0.527 |
50–59 | 26.8 | 73.2 | 1.09 | 0.63–1.88 | 0.767 | 57.9 | 42.1 | 2.04 | 1.33–3.12 | 0.001 |
60–69 | 38.6 | 61.4 | 1.86 | 1.14–3.05 | 0.013 | 55.9 | 44.1 | 1.89 | 1.25–2.84 | 0.003 |
Formal education period | ||||||||||
High school graduate and | 30.4 | 69.6 | 1 | 47.9 | 52.1 | 1 | ||||
College and higher | 31.1 | 68.9 | 0.97 | 0.69–1.35 | 0.844 | 53.9 | 46.1 | 0.79 | 0.59–1.06 | 0.109 |
Self-rated understanding of terminology | ||||||||||
High | 37.3 | 62.7 | 1 | 62.8 | 37.2 | 1 | ||||
Middle | 30.7 | 69.3 | 0.74 | 0.51–1.08 | 0.122 | 51.5 | 48.5 | 0.63 | 0.43–0.92 | 0.018 |
Low | 21.1 | 78.9 | 0.45 | 0.29–0.69 | <0.001 | 41.6 | 58.4 | 0.42 | 0.29–0.62 | <0.001 |
Awareness of benefits | ||||||||||
Helpful for disease diagnosis | 91.1 | 79.0 | 2.73 | 1.60–4.66 | <0.001 | 90.2 | 77.0 | 2.76 | 1.80–4.23 | <0.001 |
Helpful for disease treatment | 93.2 | 78.3 | 3.77 | 2.10–6.78 | <0.001 | 89.1 | 76.5 | 2.51 | 1.66–3.79 | <0.001 |
Helpful for disease prevention | 90.2 | 75.7 | 2.96 | 1.78–4.92 | <0.001 | 89.1 | 77.0 | 2.44 | 1.61–3.70 | <0.001 |
Concerns | ||||||||||
Financial infusion | 79.7 | 77.7 | 1.13 | 0.75–1.69 | 0.572 | 78.7 | 74.4 | 1.27 | 0.90–1.80 | 0.180 |
Privacy concerns | 57.7 | 61.7 | 0.85 | 0.61–1.19 | 0.339 | 56.3 | 52.8 | 1.15 | 0.86–1.55 | 0.355 |
Discriminations | 40.4 | 45.0 | 0.83 | 0.59–1.16 | 0.275 | 38.5 | 37.2 | 1.06 | 0.78–1.44 | 0.711 |
Unexpected negative effects | 34.0 | 42.8 | 0.68 | 0.49–0.97 | 0.034 | 30.5 | 32.6 | 0.91 | 0.66–1.25 | 0.564 |
Cloned human beings | 33.5 | 37.0 | 0.86 | 0.61–1.22 | 0.387 | 29.0 | 32.0 | 0.87 | 0.63–1.20 | 0.391 |
Belief | ||||||||||
Company or government bodies use genome information | 44.5 | 45.6 | 0.96 | 0.69–1.34 | 0.796 | 39.9 | 38.8 | 1.05 | 0.78–1.42 | 0.758 |